Hatori Michio, Ohki Kohji, Hirano Shin-ichi, Yang Xiao-Ping, Kuboki Hiroshi, Abe Chiyuki
R and D Center, Calpis Co., Ltd., Sagamihara-shi, Kanagawa, Japan.
Biosci Biotechnol Biochem. 2008 Aug;72(8):1983-91. doi: 10.1271/bbb.70792. Epub 2008 Aug 7.
We evaluated the effects of a casein hydrolysate (CH) prepared from Aspergillus oryzae protease on rat adjuvant arthritis, a model of human rheumatoid arthritis. CH was administered orally once a day to the animals for 22 d after the adjuvant injection. CH suppressed swelling in the adjuvant-uninjected hind paws, and a higher dose of CH suppressed the increase in arthritic score and swelling of the adjuvant-injected hind paws. A histopathological examination revealed evidence that the higher dose of CH suppressed the articular changes in the rats. In addition, CH suppressed the production of nitric oxide and prostaglandin E(2) in the plasma of the rats. These results suggest that CH had a suppressive effect on adjuvant arthritis by inhibiting the acute and chronic inflammatory reactions.
我们评估了由米曲霉蛋白酶制备的酪蛋白水解物(CH)对大鼠佐剂性关节炎(一种人类类风湿性关节炎模型)的影响。在注射佐剂后,每天给动物口服一次CH,持续22天。CH抑制了未注射佐剂的后爪肿胀,较高剂量的CH抑制了关节炎评分的增加以及注射佐剂的后爪肿胀。组织病理学检查显示,较高剂量的CH抑制了大鼠关节变化的证据。此外,CH抑制了大鼠血浆中一氧化氮和前列腺素E2的产生。这些结果表明,CH通过抑制急性和慢性炎症反应对佐剂性关节炎具有抑制作用。